Incyte
INCY
#1186
Rank
ยฃ14.91 B
Marketcap
ยฃ74.93
Share price
-0.40%
Change (1 day)
28.07%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2024: ยฃ3.37 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is ยฃ3.55 Billion. In 2024 the company made a revenue of ยฃ3.37 Billion an increase over the revenue in the year 2023 that were of ยฃ2.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2024

Annual revenue

Year Revenue Change
2024ยฃ3.37 B16.51%
2023ยฃ2.90 B3.38%
2022ยฃ2.80 B26.83%
2021ยฃ2.21 B13.08%
2020ยฃ1.95 B18.84%
2019ยฃ1.64 B11.04%
2018ยฃ1.48 B30.43%
2017ยฃ1.13 B26.84%
2016ยฃ0.89 B76.18%
2015ยฃ0.50 B54.82%
2014ยฃ0.32 B52.68%
2013ยฃ0.21 B17.08%
2012ยฃ0.18 B202.43%
2011ยฃ60.77 M-44.78%
2010ยฃ0.11 B1822.01%
2009ยฃ5.72 M114.06%
2008ยฃ2.67 M-84.57%
2007ยฃ17.33 M22.84%
2006ยฃ14.11 M210.15%
2005ยฃ4.55 M-18.88%
2004ยฃ5.6 M-78.69%
2003ยฃ26.32 M-58.46%
2002ยฃ63.37 M-58.09%
2001ยฃ0.15 B16.24%
2000ยฃ0.13 B33.85%
1999ยฃ97.19 M19.89%
1998ยฃ81.06 M49.29%
1997ยฃ54.3 M126.23%
1996ยฃ24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
ยฃ41.91 B 1,077.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ46.43 B 1,204.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ43.94 B 1,134.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ26.60 B 647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.13 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ56.03 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ69.75 M-98.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.29 B-91.73%๐Ÿ‡บ๐Ÿ‡ธ USA